Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer

Regulatory Peptides

Volumn 178, Issue 1-3, 2012, Pages 36-42

  Wang, YunXia ^a   Mao, HongLuan ^a   Hao, QingZhi ^b   Wang, Yu ^a   Yang, YongMei ^a   Shen, Liang ^a   Huang, ShanYing ^c   Liu, PeiShu ^a  

^a SHANDONG UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Chemosensitivity; Cisplatin; Epithelial ovarian cancer; Microvessel density; X linked inhibitor of apoptosis; XIAP associated factor 1

Indexed keywords

CASPASE 3; CISPLATIN; CYTOCHROME C; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; XIAP ASSOCIATED FACTOR 1 PROTEIN;

ADULT; ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RESISTANCE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CYSTADENOMA; DISEASE ASSOCIATION; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VASCULARIZATION; UPREGULATION;

ADULT; AGED; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; CYSTADENOMA; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROVESSELS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; TUMOR BURDEN; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84865362852     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.06.005     Document Type: Article

References (23)

1. Wright C.W., Duckett C.S. Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function. J Clin Invest 2005, 115:2673-2678.
2. Huang J., Yao W., Zhu Q., Tu S., Yuan F., Wang H., Zhang Y., Yuan Y. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer. Cancer Sci 2010, 101:559-567.
3. Emanuel P.O.M., Phelps R.G., Mudgil A., Shafir M., Burstein D.E. Immunohistochemical detection of XIAP in melanoma. J Cutan Pathol 2008, 35:292-297.
4. Hussain A.R., Uddin S., Ahmed M., Bu R., Ahmed S.O., Abubaker J., Sultana M., Ajarim D., Al-Dayel F., Bavi P.P., Al-Kuraya K.S. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. J Pathol 2010, 222:180-190.
5. Shaw T.J., Lacasse E.C., Durkin J.P., Vanderhyden B.C. Downregulation of XIAP expression in ovarian cancer cells induces cell death in vitro and in vivo. Int J Cancer 2008, 122:1430-1434.
6. Fong W.G., Liston P., Rajcan-Separovic E., St Jean M., Craig C., Korneluk R.G. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000, 70:113-122.
7. Liston P., Fong W.G., Kelly N.L., Toji S., Miyazaki T., Conte D., Tamai K., Craig C.G., McBurney M.W., Korneluk R.G. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 2001, 3:128-133.
8. Leaman D.W., Chawla-Sarkar M., Vyas K., Reheman M., Tamai K., Toji S., Borden E.C. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J Biol Chem 2002, 277:28504-28511.
9. Shui P.T., Yun W.S., Jian T.C., Bing Z., Lin M.C.M., Qing G., Shi H.J., Hsiang F.K., Korneluk R.G., Wong B.C.Y. Tumor suppressor XIAP-associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression. Cancer 2010, 116:1252-1263.
10. Qiao L., Gu Q., Dai Y., Shen Z., Liu X., Qi R., Ma J., Zou B., Li Z., Lan H.Y., Wong B.C.Y. XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells. Tumour Biol 2008, 29:122-129.
11. Rossochacka-Rostalska B., Gisterek I.J., Suder E., Szelachowska J.K., Matkowski R.A., Lacko A., Kornafel J.A. Prognostic significance of microvessel density in ovarian cancer. Wiad Lek 2007, 60:129-137.
12. Mandic A., Vujkov T., Novakovic P., Komazec S. Tumor angiogenesis in gynecological oncology. J BUON 2002, 7:19-23.
13. Zhao Z., Chu Y., Ye Z., Wang Y., Tao H. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol 2010, 41:686-696.
14. Yildiz E., Ayan S., Goze F., Gokce G., Gultekin E.Y. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int 2008, 101:758-764.
15. SN, von Eschenbach A.C., RG, IJF Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res 1986, 46:4109-4115.
16. Sakemi R., Yano H., Ogasawara S., Akiba J., Nakashima O., Fukahori S., Sata M., Kojiro M. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues. Oncol Rep 2007, 18:65-70.
17. Chung S., Lee M., Ryu B., Lee J., Han J., Byun D., Chae K., Lee K.Y., Jang J., Kim H., Chi S. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses. Gastroenterology 2007, 132:2459-2477.
18. Straszewski-Chavez S.L., Visintin I.P., Karassina N., Los G., Liston P., Halaban R., Fadiel A., GM XAF1 mediates tumor necrosis factor-induced apoptosis and X-linked Inhibitor of apoptosis cleavage by acting through the mitochondrial pathway. J Biol Chem 2007, 282:13059-13072.
19. David J.S. Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 2007, 63:12-31.
20. Xia Y., Novak R., Lewis J., Duckett C.S., Phillips A.C. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP. Mol Cell Biochem 2006, 286:67-76.
21. L and Mcl-1. Mol Med 2011, 17:1262-1274.
22. Shibata Tomotaka, Noguchi Tsuyoshi, Takeno Shinsuke, Gabbert Helmut E., Ramp Uwe Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas. Ann Surg Oncol 2008, 15:3579-3587.
23. Ng K.C.P., Campos E.I., Martinka M., Li G. XAF1 expression is significantly reduced in human melanoma. J Invest Dermatol 2004, 123:1127-1134.